Postoperative adjuvant cisplatin, doxorubicin, and cyclophosphamide (PAC) chemotherapy in women with high-risk endometrial carcinoma. - Burke,T.W.; Gershenson,D.M.; Morris,M.; Stringer,C.A.; Levenback,C.; Tortolero-Luna,G.; Baker,V.V. (Gynecol Oncol, 1994)